Bio Preventive Medicine Corp. (6810.TWO)

TWD 30.55

(0.16%)

Market Cap (In TWD)

1.46 Billion

Revenue (In TWD)

1.2 Million

Net Income (In TWD)

-73.28 Million

Avg. Volume

102.9 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
25.4-45.1
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006810005
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
-
Employee Count
-
Website
https://www.bpmbiotech.com
Ipo Date
2021-08-30
Details
Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It provides DNlite test, a series of patented and clinically validated non-invasive urine test for diabetic kidney disease management, such as DNlite-IVD103 and DNlite-DN_Score. The company was founded in 2014 and is headquartered in Zhubei, Taiwan.